Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis

Int J Antimicrob Agents. 2007 Jan;29(1):112-3. doi: 10.1016/j.ijantimicag.2006.08.035. Epub 2006 Nov 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / isolation & purification
  • Adolescent
  • Adult
  • Aged
  • Amikacin / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology*
  • Carbapenems / therapeutic use
  • Cefepime
  • Cefoperazone / pharmacology
  • Cephalosporins / pharmacology
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Bacterial*
  • Female
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / epidemiology
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Imipenem / pharmacology
  • Male
  • Meningitis, Bacterial / drug therapy
  • Meningitis, Bacterial / epidemiology
  • Meningitis, Bacterial / microbiology
  • Meropenem
  • Microbial Sensitivity Tests
  • Middle Aged
  • Neurosurgical Procedures / adverse effects
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology
  • Postoperative Complications / microbiology
  • Thienamycins / pharmacology
  • Turkey / epidemiology

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Cephalosporins
  • Thienamycins
  • Ciprofloxacin
  • Imipenem
  • Cefoperazone
  • Cefepime
  • Amikacin
  • Meropenem